The cohort COVID era ASX IPOs was significantly large, but there were far more dud companies than successes. During 2021, A$13bn in capital was raised and the total value of…
Today, on the first trading day of 2026, Stocks Down Under publishes its its 10 Hottest ASX Stocks to Look At in the year ahead!
What are the Best ASX Stocks…
Mere days after Artrya (ASX:AYA) obtained FDA approval for its heart-health technology, EBR Systems (ASX:EBR) has achieved that same feat.
The company made a surprising 15% plunge on the day of…
Imricor Medical Systems (ASX:IMR) is one of a handful of radiology stocks on the ASX, seeking to emulate the success of Pro Medicus (ASX:PME). There's no shortage of peers including…
FDA approval for ASX health stocks is the dream that just about all emerging companies in the sector are aspiring to. Just over 12 months ago, we predicted that Neuren…